Development of inhibitors of the oncogenic fusion proteins (NPM-ALK, RET) The main purpose of this project is to generate new knowledge on the molecular pathogenic events leading to malignant transformation in human cancers caused by oncogenic fusion protein (OFP) with tyrosine kinase (TK) activity and to exploit this information to develop innovative treatment modalities
